Effects of Quercetin, Kaempferol, and Exogenous Glutathione on Phospho- and Total-AKT in 3T3-L1 Preadipocytes

Journal of Dietary Supplements

Volumn 15, Issue 6, 2018, Pages 814-826

  Boadi, William Y ^a   Lo, Andrew ^a  

^a TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Fenton's pathway; flavonoids; glutathione; oxidative damage; phospho AKT; total AKT

Indexed keywords

GLUTATHIONE; KAEMPFEROL; KAEMPFEROL DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; QUERCETIN;

3T3-L1 CELL LINE; ADIPOCYTE; ANIMAL; CELL DIFFERENTIATION; DRUG EFFECT; ENZYMOLOGY; MOUSE; OXIDATION REDUCTION REACTION; PHOSPHORYLATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; GLUTATHIONE; KAEMPFEROLS; MICE; OXIDATION-REDUCTION; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; QUERCETIN;

EID: 85040967192     PISSN: 19390211     EISSN: 1939022X     Source Type: Journal    
DOI: 10.1080/19390211.2017.1401572     Document Type: Article

References (37)

1. Aksamitiene E, Kiyatkin A, Kholodenko BN. 2012. Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: A fine balance. Biochem Soc Trans. 40:139–146.
2. Ament Z, West JA, Stanley E, Ashmore T, Roberts LD, Wright J, Nicholls AW, Griffin JL. 2016. PPAR-pan activation induces hepatic oxidative stress and lipidomic remodeling. Free Rad. Biol Med. 95:357–368.
3. Alyasiri NS, Mehdi SJ, Alam MS, Ali A, Mandal AK, Gupta S, Singh I, Rizvi MMA. 2012. PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients. J. Can Res Clin Oncol. 138:103–109.
4. Arsenijevic T, Grégoire F, Delforge V, Delporte C, Perret J., 2012. Murine 3T3-L1 adipocyte cell differentiation model: validated reference genes for qPCR gene expression analysis. PLOS ONE. 7(5):e37517.
5. Baudry A, Yang ZZ, Hemmings BA. 2006. PKBα is required for adipose differentiation of mouse embryonic fibroblasts. J Cell Sci. 119:889–897.
6. Boadi WY, Harris S, Anderson JB, Adunyah SE. 2013. Lipid peroxides and glutathione status in human progenitor mononuclear (U937) cells following exposure to low doses of nickel and copper. Drug Chem Toxicol. 36:155–162.
7. Boadi WY, Iyere PA, Adunyah SE. 2003. Effect of quercetin and genistein on copper- and iron-induced lipid peroxidation in methyl linolenate. J Appl Toxicol. 23:363–369.
8. Boadi WY, Amartey P, Lo A. 2016. Effect of quercetin, genistein and kaempferol on glutathione and glutathione-redox cycle enzymes in 3T3-L1 preadipocytes cells. Drug Chem Toxicol. 39:239–247.
9. Calzadilla P, Sapochnik D, Cosentino S, Diz V, Dicelio L, Calvo JC, Guerra LN. 2011. N-Acetylcysteine Reduces Markers of Differentiation in 3T3-L1 Adipocytes. Int. J. Mol. Sci. 12:6936–5951.
10. Cowan LS, Diem L, Brake MC, Crawford JT. 2004. Transfer of a Mycobacterium tuberculosis genotyping method, spoligotyping, from a reverse line-blot hybridization, membrane assay to the luminex multianalyte profiling system. J Clin Micro. 42:474–477.
11. Cristancho AG, Lazar MA. 2011. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol. 12:722–734.
12. Entenmann G, Hauner H. 1996. Relationship between replication and differentiation in cultured human adipocyte precursor cells. Am. J. Physiol. Cell Physiol. 270:c1011–c1106.
13. Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M. 2004. PI3K/Akt signaling pathway and cancer. Cancer Treat Rev. 30:193–204.
14. Green H, Kehinde O. 1976. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 7:105–113.
15. Green CJ, Göransson O, Kular GS, Leslie NR, Gray A, Alessi DR, Sakamoto K, Hundal HS. 2008. Use of Akt inhibitor and a drug-resistant mutant validates a critical role for protein kinase B/Akt in the insulin-dependent regulation of glucose and system amino acid uptake. J Biol Chem. 283:27653–27667.
16. Harmon AW, Patel YM. 2003. Naringenin inhibits phosphoinositide 3-kinase activity and glucose uptake in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 30:229–234.
17. Kennedy LJ, Moore K, Jr, Caufield JL, Tannenbaum SR, Dedon PC. 1997. Quantitation of 8-oxoguanine and strand breaks produced by four oxidizing agents. Chem Res Toxicol. 10:386–392.
18. Kim G-S, Park HJ, Woo J-H, Kim MK, Koh P-O, Min W, Ko Y-G, Kim C-H, Won C-K, Cho J-H. 2012. Citrus aurantum flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells. Compl Alt Med. 12:31–41.
19. Laukkanen JA, Laaksonen DE, Niskanen L, Pukkala E, Hakkarainen A, and Salonen JT. 2004. Metabolic Syndrome and the Risk of Prostate Cancer in Finnish Men: A Population-Based Study. Cancer Epidemiol Biomarkers Prev 13:1646–1650.
20. Leggatt RA, and Iwama GK. 2009. Exogenous glutathione can increase glutathione levels in tissues of rainbow trout (Oncorhynchus mykiss) through extracellular breakdown and intracellular synthesis. Comp Biochem Physiol. Part C 150:322–328.
21. Lefterova MI, Lazar MA. 2009. New developments in adipogenesis. Trends Endocrinol Metab. 20:107–114.
22. Li Y, Wang Z, Kong D, Li R, Sarkar SH, Sarkar FH. 2008. Regulation of Akt/FOXO3a/GSK-3/AR Signaling Network by Isoflavone in Prostate Cancer Cells. J Biol Chem 283:27707–27716.
23. Lin J, Della-Fera MA, Baile CA. 2005. Green tea polyphenol epgallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes. Obes Res. 13:982–990.
24. Matter WF, Brown RF, Vlahos CJ. 1992. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem Biophys Res Commun. 186:624–631.
25. Nixon T, Green H. 1984. Contribution of growth hormone to the adipogenic activity of serum. Endocrinology 114:527–532.
26. Otto TC, Lane MD. 2005. Adipose development: from stem cell to adipocyte. Crit Rev Biochem Mol Biol. 40:229–242.
27. Ramos AM, Aller P. 2008. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Biochem Pharmacol. 75:1912–1923.
28. Ruan H, Hacohen N, Golub TR, Parijs LV, Lodish HF. 2002. Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 Adipocytes. Diabetes 51:1319–1336.
29. Schuster DP. 2010. Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation. Diabetes Metab Syndr Obes. 16:253–262.
30. Spencer JPE, Rice-Evans C, Williams RJ. 2003. Modulation of Pro-survival Akt/Protein Kinase B and ERK1/2 Signaling Cascades by Quercetin and Its in Vivo Metabolites Underlie Their Action on Neuronal Viability. J Biol Chem. 278:34783–34793.
31. Vanhaesebroeck B, Alessi DR., 2000. The PI3K-PDK1 connection: More than just a road to PKB. Biochemical Journal. 15:561–576.
32. Takahashi T, Tabuchi T, Tamaki Y, Kosaka K, Takikawa Y, Satoh T., 2009. Carnosic and carnosol inhibit adipocyte differentiation in mouse 3T3-L1 cells through induction of phase2 enzymes and activation of glutathione metabolism. Biochem Biophys Res Commun. 382:549–554.
33. Willems L, Tamburini J, Chapuis N, Lacombe C, Mayeux P, Bouscary D. 2012. PI3K and mTOR signaling pathways in cancer: New data on targeted therapies. Curr Oncol Rep. 14: 129–138.
34. Xu J, Liao K. 2004. Protein kinase B/Akt 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation. J Biol Chem. 279:35914–35922.
35. Vlahos CJ, Matter WF, Hui KY, Brown RF. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 269:5241–5248.
36. Zhang HH, Huang J, Düvel K, Boback B, Wu S, Squillace RM, Wu CL, Manning BD. 2009. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One. 4:e6189.
37. Zhou Q, Lui VW, Yeo W. 2011. Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Future Oncol. 7:1149–1167.